Vu offers GLP-1 weight loss injections to help patients achieve their health and aesthetic goals
Rodriguez, conducted a cohort study involving 125,474 patients who started GLP-1 medications, including Victoza (liraglutide), Ozempic and Wegovy, and Mounjaro and Zepbound between January 1, 2018 and December 31, 2023
Self-Perception Questionnaire (SPQ): Subjects completed a 20-question questionnaire at Week 12, rating their agreement with statements about their skin using a five-point Likert scale
Patients should have access to a team that can adjust treatment, answer questions, and help integrate medication use with nutrition, movement, and behavior changes, adds Dr
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
Product Format